Journal
FEBS LETTERS
Volume 586, Issue 24, Pages 4311-4318Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2012.10.037
Keywords
ANKHD1; Multiple myeloma; Proliferation; Cell cycle; p21
Funding
- Instituto Nacional de Ciencia e Tecnologia do Sangue(INCTS)
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil
Ask authors/readers for more resources
ANKHD1 is a multiple ankyrin repeat containing protein, highly expressed in cancers, such as acute leukemia. The present study was undertaken to determine the expression and functional significance of ANKHD1 in human Multiple Myeloma (MM). We found that ANKHD1 is highly expressed in MM patient cells and cell lines. In vitro, lentiviral mediated ANKHD1-shRNA inhibited proliferation and delayed S to G2M cell cycle progression in glucocorticoid resistant (U266) and sensitive (MM1S) MM cells. Further ANKHD1 silencing resulted in upregulation of cyclin dependent kinase inhibitor p21 irrespective of the p53 status of the MM cell lines. These data suggest that ANKHD1 might have a role in MM cell proliferation and cell cycle progression by regulating expression of p21. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available